Editorial Standards

NEURAMIND publishes ingredient, dose and supplement-label education so readers can inspect the evidence and its limits. Our journal is educational content, not medical advice, and it does not replace care from a qualified professional.

Who writes the journal

The NEURAMIND Research Desk is the brand's editorial team. Articles are prepared from the product label, primary research and authoritative public-health or regulatory sources. We do not present the Research Desk as a doctor, clinic or independent medical-review board.

Our source standard

• Prefer systematic reviews, meta-analyses, randomized human trials, official monographs and regulator guidance.
• Link sources close to the claim so readers can inspect them.
• State the studied dose, population and outcome when those details materially change the conclusion.
• Do not treat a study of one ingredient as proof that a finished multi-ingredient formula produces the same result.

How commercial content is handled

NEURAMIND sells the products discussed on this website. Product links may therefore have a commercial purpose. That relationship is stated here rather than disguised. Educational pages must still distinguish label facts from research findings and must not invent disease-treatment claims, guarantees or credentials.

Review dates and updates

Journal pages display publication and update dates. We revisit an article when its sources, product-label facts or safety context materially change. A formatting change alone does not justify presenting an article as newly reviewed.

Corrections policy

If a factual error is confirmed, we correct the article, update its modification date and preserve an explanatory correction note when the change could affect a reader's interpretation. To report an error, email [email protected] with the article URL, the sentence in question and a source supporting the correction.

Safety boundary

Supplements are not intended to diagnose, treat, cure or prevent disease. Individual responses vary. People who take medication, have a medical condition, are pregnant or breastfeeding, or are under 18 should seek qualified guidance before using a supplement.

Read the journal or learn more about NEURAMIND.